Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Human Insulin Market Estimated to Register a CAGR of 12.1 % By 2027: Asserts MRFR

Market Research Future
Posted on: 26 Jul 17

PUNE, India, July 26, 2017 /PRNewswire/ -- Market Research Future published a cooked research report on "Global Human Insulin Market Research Report - Forecast to 2027" – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027.

Biocon Ltd. (India), Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Adocia (France.), Merck & Co. (U.S.), Julphar (UAE), Bristol-Myers Squibb Company (U.S.), GlaxoSmithKline Plc (U.K.), Oramed Pharmaceuticals, Inc. (Israel), Novo Nordisk A/S (Denmark), Pfizer, and Sanofi are some of the prominent players competing in the Global Human Insulin Market and are profiled in MRFR Analysis.  

Human Insulin Global Market – Overview

The Human Insulin Market is growing with the rapid pace; mainly due to the increasing prevalence of diabetic population. According to a recent study report published by the Market Research Future, the global Human Insulin market is forecasted to gain prominence over the forthcoming years. The market is expected to grow at a rapid pace during the forecast period. The Human Insulin Market is projected to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking two-digit CAGR of 12.1% during the anticipated period (2016 – 2027).

The major factors contributing to the market growth are; increase in prevalence of diabetic population, rise in geriatric population, rising awareness of diabetes and rising prevalence of obesity. However, strict regulatory requirements for approval of insulin and high cost of analog are inhibiting the growth of the global human insulin market. Along with that, delayed onset of action, and various side effects of human insulin are also limiting the growth of this market across the globe.

Although insulin has been used in the treatment of diabetes for over 90 years, globally more than half of those who need insulin today still cannot afford it. Without insulin, people living with type 1 diabetes will die. Many more will suffer from diabetes-related complications, like blindness, amputation and kidney failure, and, ultimately, premature death. There are many complex issues that affect access to this life-saving medicine, creating inequity and inefficiency in the global insulin market. These issues include the global insulin market domination by three multinational manufacturers, import duties affecting the price insulin entering different countries, and mark-ups, taxes and other charges in the public and private sector supply chains that affect the final patient price.

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/849

Human Insulin Global Market – Competitive Analysis

The MRFR analysis comprises key players of the global insulin market such as insulin manufacturers as independent and licensed manufacturers, subsidiaries, and distributors of the global insulin market. Characterized by the presence of several well-established and small players, the global Market of Human Insulin appears to be highly competitive. Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position. Manufacturers invest heavily in to developing pipeline of innovative projects to address unmet patient needs.  Investment activities in the Human Insulin Market are interpreted as capacity expansion plan and intensive R&D with an aim of obtaining vast growth opportunities.

Human Insulin Global Market – Segments

The Human Insulin Market can be segmented in to 3 key dynamics for the convenience of the report and enhanced understanding;

Segmentation by Traditional Human Insulin:  Comprises Short Acting Human Insulin, Intermediate Acting Human Insulin, and Premixed Human Insulin.

Segmentation by Modern Human Insulin: Comprises Long Acting Human Insulin, Rapid Acting Human Insulin and Premixed Human Insulin.

Segmentation by Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Based on the type, modern human insulin has the largest market share in the human insulin market

Human Insulin Global Market – Synopsis

With the worldwide increasing prevalence of diabetes, the insulin market is growing as well widening. Additionally, rising prevalence of obesity, and rise in geriatric population are major factors driving the growth of the human insulin market. While, strict regulatory requirements for approval of insulin and high cost of insulin analog constrains the growth of the human insulin market. Although the prevalence of diabetes is increasing globally and access to insulin continues to be a problem, it does not appear currently that the problem is lack of global supply.

Browse Report @ https://www.marketresearchfuture.com/reports/global-human-insulin-market-849

Human Insulin Market – Regional Analysis

Geographically, North America has the largest share in global human insulin market; large share of this market is attributed to the growing prevalence of diabetes and obesity. North America is a prominent market for human insulin market and dominated the Global market share. It has been valued at $11,127.9 in 2015 million and is expected to grow over astronomical amounts by 2027. The North American market for human insulin is expected to grow at a significant rate of CAGR during the forecasted period. Europe is the second-largest market for human insulin, which is expected to grow with a CAGR of 12.2% during the forecasted period. Asia Pacific has emerged as the fastest growing market which has been valued at US $6,298 million in 2015 and expected to reach to multimillions USD by the end of forecasted period with the CAGR of more than 13.2%.

Browse Related Report

Epsom Salt Market Segmentation- by Form Type (Granules, Powder, Crystal, Bath Bombs), by Application (Agriculture, Food Additives & Pharmaceutical, Personal Care & Home Care, Chemical & Industrial and others) by Distribution Channel (Store Based, Non-Store Based) and Region - Forecast to 2027

https://www.marketresearchfuture.com/reports/epsom-salt-market-2979

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

For more information:
www.marketresearchfuture.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.